Artikel dengan mandat akses publik - Owen A. RossPelajari lebih lanjut
KeseluruhanNIHMichael J Fox FoundationDoDParkinson's Foundation, USACIHRMRCWellcomeNIHRFlorida Department of Health, USAFRQSDFGParkinson's UKGovernment of SpainAlzheimers's UKSNSFNHMRCINSERMSwedish Research CouncilEuropean CommissionVABMBFFWONRFGenome CanadaNAWANSERCGovernment of ItalyAHAZonMwFWFAcademy of FinlandTelethonRCNHelmholtzVolkswagen FoundationDFFBHFESRCMotor Neurone Disease Association, UKANRASAPCanada First Research Excellence FundNSFHHMIDCTIDNRFBanking Foundation "la Caixa"HRBNWOKnut and Alice Wallenberg FoundationCancer Research UKARRSPCORINMRCNCNBrain Research, UKCZIDOENSFCSFIFORTEA*StarBBSRCCSODMTEPSRCSTFCDoris Duke Charitable FoundationAXA Research Fund, FranceHealth Data Research, UK
Tidak tersedia di mana pun: 21
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease
O Cooper, H Seo, S Andrabi, C Guardia-Laguarta, J Graziotto, ...
Science translational medicine 4 (141), 141ra90-141ra90, 2012
Mandat: US National Institutes of Health
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
OA Ross, YR Wu, MC Lee, M Funayama, ML Chen, AI Soto, IF Mata, ...
Annals of Neurology: Official Journal of the American Neurological …, 2008
Mandat: US National Institutes of Health
Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP‐17) due to microtubule‐associated protein tau (MAPT) p. P301L mutation …
P Tacik, M Sanchez‐Contreras, M DeTure, ME Murray, R Rademakers, ...
Neuropathology and Applied Neurobiology 43 (3), 200-214, 2017
Mandat: US National Institutes of Health, Florida Department of Health, USA
SNCA, MAPT, and GSK3B in Parkinson disease: a gene–gene interaction study
C Wider, C Vilariño‐Güell, MG Heckman, B Jasinska‐Myga, ...
European Journal of Neurology 18 (6), 876-881, 2011
Mandat: Swiss National Science Foundation, US National Institutes of Health …
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease
M Sharma, DM Maraganore, JPA Ioannidis, O Riess, JO Aasly, G Annesi, ...
Neurobiology of aging 32 (11), 2108. e1-2108. e5, 2011
Mandat: US National Institutes of Health, Research Foundation (Flanders)
Reported mutations in GIGYF2 are not a common cause of Parkinson's disease
C Vilariño‐Güell, OA Ross, AI Soto, MJ Farrer, K Haugarvoll, JO Aasly, ...
Movement Disorders 24 (4), 619-620, 2009
Mandat: US National Institutes of Health
Alpha‐synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population
A Rajput, C Vilariño‐Güell, ML Rajput, OA Ross, AI Soto‐Ortolaza, ...
Movement disorders 24 (16), 2411-2414, 2009
Mandat: US National Institutes of Health, National Institute of Health and Medical …
Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease
B Behrouz, C Vilariño-Güell, MG Heckman, AI Soto-Ortolaza, JO Aasly, ...
Neuroscience letters 486 (3), 228-230, 2010
Mandat: US National Institutes of Health, Canadian Institutes of Health Research
Magnetic resonance spectroscopy as a biomarker for chronic traumatic encephalopathy
ML Alosco, J Jarnagin, B Rowland, H Liao, RA Stern, A Lin
Seminars in neurology 37 (05), 503-509, 2017
Mandat: US National Institutes of Health
Cilostazol versus aspirin for secondary stroke prevention: systematic review and meta-analysis
MP Lin, JF Meschia, N Gopal, KM Barrett, OA Ross, N Ertekin-Taner, ...
Journal of Stroke and Cerebrovascular Diseases 30 (3), 105581, 2021
Mandat: US National Institutes of Health
LRRK2: Genetic mechanisms vs genetic subtypes
I Mata, P Salles, M Cornejo-Olivas, P Saffie, OA Ross, X Reed, ...
Handbook of clinical neurology 193, 133-154, 2023
Mandat: Aligning Science Across Parksinson's, USA
Death‐associated protein kinase 1 variation and Parkinson’s disease
JC Dachsel, C Wider, C Vilariño‐Güell, JO Aasly, A Rajput, AH Rajput, ...
European Journal of Neurology 18 (8), 1090-1093, 2011
Mandat: US National Institutes of Health, Canadian Institutes of Health Research
Role of GBA variants in Lewy body disease neuropathology
RL Walton, S Koga, AI Beasley, LJ White, T Griesacker, ME Murray, ...
Acta neuropathologica 147 (1), 54, 2024
Mandat: Michael J Fox Foundation
DCTN1 variation in pathologically-confirmed PSP and CBD tauopathy
M Sanchez-Contreras, AI Soto, RL Walton, ZK Wszolek, DW Dickson, ...
Parkinsonism & Related Disorders 44, 151-153, 2017
Mandat: US National Institutes of Health
A novel link between trafficking and Lewy body disorders
OA Ross, G Bu
The Lancet Neurology 17 (7), 571-573, 2018
Mandat: US Department of Defense, US National Institutes of Health
PTPA variants are rare in early-onset and familial Parkinson’s disease
J Dulski, AI Soto-Beasley, RJ Uitti, ZK Wszolek, OA Ross
Brain 146 (12), e125-e127, 2023
Mandat: Michael J Fox Foundation
Driving genotype treatment options down the right path (way)
OA Ross, IF Mata
Movement Disorders 34 (12), 1811-1813, 2019
Mandat: US National Institutes of Health, Parkinson's Foundation, USA
Associations of mitochondrial genomic variation with successful neurological aging
N Tamvaka, MG Heckman, PW Johnson, AI Soto-Beasley, RL Walton, ...
Mitochondrion 78, 101948, 2024
Mandat: Michael J Fox Foundation
Mayo Clinic Florida Morris K. Udall Center of Excellence for Parkinson's Research
A Strongosky, R Rademakers, O Ross, R Uitti, J Van Gerpen, Z Wszolek, ...
Parkinsonism & Related Disorders 22, e166, 2016
Mandat: US National Institutes of Health
Exome Variant Mining in Familial Parkinson Disease: Will Replication Find the Gold?
M Toft, OA Ross
JAMA neurology 73 (1), 21-22, 2016
Mandat: US National Institutes of Health, Research Council of Norway
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer